Earnings ·
Perrigo Company plc reported second quarter 2026 financial results for the period ended June 27, 2026
PRGOPERRIGO Co plc
Perrigo Company plc reported second quarter 2026 financial results for the period ended June 27, 2026. Reported diluted earnings per share were $0.63, compared to $0.00 in the prior year, driven by a $129.4 million gain on the sale of its Dermacosmetics business. Core net sales declined 3.1% year-over-year to $907 million, while core adjusted diluted EPS fell 20.7% to $0.46. The company reaffirmed its full-year 2026 outlook, projecting adjusted EPS between $2.00 and $2.30 on an All-In basis. Perrigo operates in the consumer self-care and over-the-counter health products industry.